Wall Street and the Fed will get more insight next week on inflation’s temperature and the economy. The government will ...

Gilead Sciences, Inc. (NASDAQ:GILD) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Gilead Sciences, Inc.

U.S. stocks are drifting near their record heights as Wall Street waits for an upcoming update on inflation.

• Mount Gilead at Upper Sandusky, girls’ golf, 1:30 p.m. • Mount Gilead, Fredericktown and Harding at Cardington, boys’ golf, 4:30 p.m. • Northmor at Margaretta, girls’ golf, 5 p.m. • Highland at ...

Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...

A Menlo Park medical device startup is breathing new life into the fight against severe emphysema with a groundbreaking ...

The global HIV antivirals market is set for a period of robust growth, with a new forecast predicting its value will climb from an estimated USD 34.8 billion in 2025 to USD 53.6 billion by 2035. This ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

Deutsche Bank analyst James Shin raised the firm’s price target on Gilead (GILD) to $135 from $120 and keeps a Buy rating on the shares. Published ...

Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis ...